CH473116A - Verfahren zur Herstellung von Lactonen und deren Verwendung - Google Patents

Verfahren zur Herstellung von Lactonen und deren Verwendung

Info

Publication number
CH473116A
CH473116A CH132966A CH132966A CH473116A CH 473116 A CH473116 A CH 473116A CH 132966 A CH132966 A CH 132966A CH 132966 A CH132966 A CH 132966A CH 473116 A CH473116 A CH 473116A
Authority
CH
Switzerland
Prior art keywords
lactones
production
Prior art date
Application number
CH132966A
Other languages
German (de)
English (en)
Inventor
B Hodge Edward
H Hidy Phil
L Wehrmeister Herbert
Original Assignee
Commercial Solvents Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commercial Solvents Corp filed Critical Commercial Solvents Corp
Priority to CH495769A priority Critical patent/CH477436A/de
Publication of CH473116A publication Critical patent/CH473116A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
    • A23K20/126—Lactones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
CH132966A 1965-02-15 1966-02-01 Verfahren zur Herstellung von Lactonen und deren Verwendung CH473116A (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CH495769A CH477436A (de) 1965-02-15 1966-02-01 Verfahren zur Herstellung eines Lactons und dessen Verwendung

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43282665A 1965-02-15 1965-02-15

Publications (1)

Publication Number Publication Date
CH473116A true CH473116A (de) 1969-05-31

Family

ID=23717744

Family Applications (1)

Application Number Title Priority Date Filing Date
CH132966A CH473116A (de) 1965-02-15 1966-02-01 Verfahren zur Herstellung von Lactonen und deren Verwendung

Country Status (12)

Country Link
US (1) US3239345A (US08124317-20120228-C00026.png)
AT (1) AT267772B (US08124317-20120228-C00026.png)
BE (1) BE675969A (US08124317-20120228-C00026.png)
BR (1) BR6676850D0 (US08124317-20120228-C00026.png)
CH (1) CH473116A (US08124317-20120228-C00026.png)
DE (1) DE1543395B1 (US08124317-20120228-C00026.png)
DK (2) DK115777B (US08124317-20120228-C00026.png)
ES (1) ES322894A1 (US08124317-20120228-C00026.png)
GB (1) GB1107738A (US08124317-20120228-C00026.png)
IL (1) IL25085A (US08124317-20120228-C00026.png)
NL (1) NL6601185A (US08124317-20120228-C00026.png)
SE (2) SE347258B (US08124317-20120228-C00026.png)

Families Citing this family (121)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3453367A (en) * 1966-06-29 1969-07-01 Commercial Solvents Corp Methods for treating inflammation with estrogenic compounds
US3574235A (en) * 1967-06-06 1971-04-06 Commercial Solvents Corp Separation of mixture of diastereo-isomers of zearalanol
US3860616A (en) * 1969-05-01 1975-01-14 Merck & Co Inc Synthesis of d,1-zearalanol
US3697548A (en) * 1970-04-02 1972-10-10 Commercial Solvents Corp Zearalenone reduction
US3687982A (en) * 1971-03-09 1972-08-29 Commercial Solvents Corp Separation of mixed diastereoisomers of zearalanol
US3965274A (en) * 1972-07-20 1976-06-22 Commercial Solvents Corporation Method of preventing pregnancy with lactone derivatives
US3965275A (en) * 1974-02-11 1976-06-22 Commercial Solvents Corporation Composition and method
US4035504A (en) * 1975-05-12 1977-07-12 Imc Chemical Group, Inc. Method for treating cholesterolemia by administering resorcylic acid lactone derivatives
US4148808A (en) * 1975-08-22 1979-04-10 Int Minerals & Chem Corp Method for reducing zearalenone
US4010167A (en) * 1975-08-22 1977-03-01 Imc Chemical Group, Inc. Method for the recovery of zearalenone
DE2637972C2 (de) * 1976-08-24 1986-03-20 Fishman, Avraham Schöpfkelle mit eingebauter Federwaage
US4069339A (en) * 1977-02-22 1978-01-17 American Cyanamid Company Novel method for the depression of fat deposition in swine
FR2388560A1 (fr) * 1977-04-27 1978-11-24 Roussel Uclaf Nouvelles compositions zootechniques renfermant d'une part le zeranol et d'autre part un steroide 4,9,11 trienique
US4239772A (en) * 1979-05-30 1980-12-16 International Minerals & Chemical Corp. Allyl and propyl zearalenone derivatives and their use as growth promoting agents
US4409392A (en) * 1981-09-03 1983-10-11 International Minerals & Chemical Corp. 6' Esters of zearalanol
US4443470A (en) * 1981-09-03 1984-04-17 International Minerals & Chemical Corp. Method of promoting growth and enhancing feed efficiency in meat producing animals
US4410512A (en) * 1981-12-28 1983-10-18 Beckman Instruments, Inc. Combinations having synergistic pituitary growth hormone releasing activity
FR2571372B1 (fr) * 1984-07-25 1987-05-22 Panmedica Sa Procede de separation des diastereoisomeres du zearalanol
US4670249A (en) * 1985-04-12 1987-06-02 International Minerals & Chemical Corp. Growth-promoting compositions
US4690948A (en) * 1986-12-01 1987-09-01 International Minerals & Chemical Corp. Halogenated resorcylic acid lactone derivatives
US4751239A (en) * 1987-06-29 1988-06-14 International Minerals & Chemical Corp. 6' Carbonate esters of zearalanol and its derivatives
US4778821A (en) * 1987-07-15 1988-10-18 International Minerals & Chemical Corp. Method for controlling helmintic parasites
EP0300325B1 (en) * 1987-07-20 1993-06-16 COMETEC S.r.l. Compositions for promoting growth of animals
US4902711A (en) * 1988-01-19 1990-02-20 Pitman-Moore, Inc. 6' Carbamate esters of zearalanol and its derivatives
IT1216059B (it) * 1988-03-11 1990-02-22 Crc Ricerca Chim Procedimento per la separazione di diastereomeri macrociclici.
US4886899A (en) * 1988-07-05 1989-12-12 Pitman-Moore, Inc. Housefly chemosterilants
US5206235A (en) * 1991-03-20 1993-04-27 Merck & Co., Inc. Benzo-fused lactams that promote the release of growth hormone
US5283241A (en) * 1992-08-28 1994-02-01 Merck & Co., Inc. Benzo-fused lactams promote release of growth hormone
US5583130A (en) * 1992-09-25 1996-12-10 Merck & Co., Inc. Benzo-fused lactams promote release of growth hormone
US5317017A (en) * 1992-09-30 1994-05-31 Merck & Co., Inc. N-biphenyl-3-amido substituted benzolactams stimulate growth hormone release
US5284841A (en) * 1993-02-04 1994-02-08 Merck & Co., Inc. Benzo-fused lactams promote release of growth hormone
US5438136A (en) * 1993-11-02 1995-08-01 Merck & Co., Inc. Benzo-fused macrocycles promote release of growth hormone
US5494919A (en) * 1993-11-09 1996-02-27 Merck & Co., Inc. 2-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
US5492920A (en) * 1993-12-10 1996-02-20 Merck & Co., Inc. Piperidine, pyrrolidine and hexahydro-1H-azepines promote release of growth hormone
US5492916A (en) * 1993-12-23 1996-02-20 Merck & Co., Inc. Di- and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
US5721251A (en) * 1993-12-10 1998-02-24 Merck & Co., Inc. Piperidine, pyrrolidine and hexahydro-1H-azepines promote release of growth hormone
US5606054A (en) * 1993-12-14 1997-02-25 Merck & Co., Inc. Heterocyclic-fused lactams promote release of growth hormone
US5721250A (en) * 1993-12-23 1998-02-24 Merck & Co. Inc. Di-and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
WO1995034311A1 (en) * 1994-06-13 1995-12-21 Merck & Co., Inc. Piperazine compounds promote release of growth hormone
US5656606A (en) * 1995-02-17 1997-08-12 Merck & Co., Inc. Camphor compounds promote release of growth hormone
US5731317A (en) * 1995-03-10 1998-03-24 Merck & Co., Inc. Bridged piperidines promote release of growth hormone
US5559128A (en) * 1995-04-18 1996-09-24 Merck & Co., Inc. 3-substituted piperidines promote release of growth hormone
JP3133073B2 (ja) * 1995-05-29 2001-02-05 ファイザー・インコーポレーテッド 成長ホルモンの放出を促進するジペプチド類
CA2240186A1 (en) 1995-12-13 1997-06-19 Merck & Co., Inc. Assays for growth hormone secretagogue receptors
US6531314B1 (en) 1996-12-10 2003-03-11 Merck & Co., Inc. Growth hormone secretagogue receptor family
US6682908B1 (en) 1998-07-10 2004-01-27 Merck & Co., Inc. Mouse growth hormone secretagogue receptor
JP2002520011A (ja) 1998-07-13 2002-07-09 メルク・アンド・カンパニー・インコーポレーテッド 成長ホルモン分泌促進物質関連受容体および核酸
WO2000009538A2 (en) 1998-08-10 2000-02-24 Merck & Co., Inc. Canine growth hormone secretagogue receptor
US6380184B1 (en) 1998-10-28 2002-04-30 Bristol-Myers Squibb Co. Benzoazepines and analogs thereof useful as growth hormone secretagogues
US6498153B1 (en) 1998-12-31 2002-12-24 Akzo Nobel N.V. Extended release growth promoting two component composition
KR100699404B1 (ko) 1999-02-18 2007-03-23 가켄 세야쿠 가부시키가이샤 성장 호르몬 분비촉진제로서의 신규 아미드 유도체
US6518292B1 (en) * 1999-03-12 2003-02-11 Bristol-Myers Squibb Co. Heterocyclic aromatic compounds usefuls as growth hormone secretagogues
US6525203B1 (en) 1999-03-12 2003-02-25 Bristol-Myers Squibb Company Heterocyclic aromatic compounds useful as growth hormone secretagogues
US7645898B2 (en) * 2000-08-24 2010-01-12 University Of Tennessee Research Foundation Selective androgen receptor modulators and method of use thereof
US7919647B2 (en) 2000-08-24 2011-04-05 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
US7622503B2 (en) 2000-08-24 2009-11-24 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
US7855229B2 (en) * 2000-08-24 2010-12-21 University Of Tennessee Research Foundation Treating wasting disorders with selective androgen receptor modulators
WO2003041643A2 (en) * 2001-11-09 2003-05-22 Conforma Therapeutics Corporation Hsp90-inhibiting zearalanol compounds and methods of producing and using same
US8853266B2 (en) * 2001-12-06 2014-10-07 University Of Tennessee Research Foundation Selective androgen receptor modulators for treating diabetes
US20070161608A1 (en) * 2001-12-06 2007-07-12 Dalton James T Selective androgen receptor modulators for treating muscle wasting
US6831102B2 (en) * 2001-12-07 2004-12-14 Bristol-Myers Squibb Company Phenyl naphthol ligands for thyroid hormone receptor
US20030199514A1 (en) * 2002-03-27 2003-10-23 Fryburg David A. Methods for improving efficacy of treatment with growth hormone secretagogues
CA2482940A1 (en) * 2002-04-17 2003-10-23 Taisho Pharmaceuticals Co., Ltd. Hair growth tonic
US6747048B2 (en) 2002-05-08 2004-06-08 Bristol-Myers Squibb Company Pyridine-based thyroid receptor ligands
US7405234B2 (en) * 2002-05-17 2008-07-29 Bristol-Myers Squibb Company Bicyclic modulators of androgen receptor function
TW200407324A (en) * 2002-05-17 2004-05-16 Bristol Myers Squibb Co Bicyclic modulators of androgen receptor function
MY139563A (en) 2002-09-04 2009-10-30 Bristol Myers Squibb Co Heterocyclic aromatic compounds useful as growth hormone secretagogues
US6653288B1 (en) 2002-09-30 2003-11-25 Virbac S.A. Injectable anthelmintic compositions and methods for using same
US7632858B2 (en) * 2002-11-15 2009-12-15 Bristol-Myers Squibb Company Open chain prolyl urea-related modulators of androgen receptor function
US8309603B2 (en) 2004-06-07 2012-11-13 University Of Tennessee Research Foundation SARMs and method of use thereof
US20040176425A1 (en) * 2003-01-24 2004-09-09 Washburn William N. Cycloalkyl containing anilide ligands for the thyroid receptor
TW200504021A (en) * 2003-01-24 2005-02-01 Bristol Myers Squibb Co Substituted anilide ligands for the thyroid receptor
US20060148776A1 (en) * 2003-03-13 2006-07-06 Conforma Therapeutics Corporation Drug formulations having long and medium chain triglycerides
US7557143B2 (en) * 2003-04-18 2009-07-07 Bristol-Myers Squibb Company Thyroid receptor ligands
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
US7256208B2 (en) * 2003-11-13 2007-08-14 Bristol-Myers Squibb Company Monocyclic N-Aryl hydantoin modulators of androgen receptor function
US7820702B2 (en) 2004-02-04 2010-10-26 Bristol-Myers Squibb Company Sulfonylpyrrolidine modulators of androgen receptor function and method
US20050182105A1 (en) * 2004-02-04 2005-08-18 Nirschl Alexandra A. Method of using 3-cyano-4-arylpyridine derivatives as modulators of androgen receptor function
US7378426B2 (en) 2004-03-01 2008-05-27 Bristol-Myers Squibb Company Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
US7625923B2 (en) 2004-03-04 2009-12-01 Bristol-Myers Squibb Company Bicyclic modulators of androgen receptor function
US7388027B2 (en) * 2004-03-04 2008-06-17 Bristol-Myers Squibb Company Bicyclic compounds as modulators of androgen receptor function and method
US7696241B2 (en) 2004-03-04 2010-04-13 Bristol-Myers Squibb Company Bicyclic compounds as modulators of androgen receptor function and method
US9884038B2 (en) 2004-06-07 2018-02-06 University Of Tennessee Research Foundation Selective androgen receptor modulator and methods of use thereof
US9889110B2 (en) 2004-06-07 2018-02-13 University Of Tennessee Research Foundation Selective androgen receptor modulator for treating hormone-related conditions
UA87854C2 (en) 2004-06-07 2009-08-25 Мерк Энд Ко., Инк. N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
US20110237664A1 (en) * 2004-06-07 2011-09-29 Dalton James T Selective androgen receptor modulators for treating diabetes
US8143425B2 (en) * 2004-10-12 2012-03-27 Bristol-Myers Squibb Company Heterocyclic aromatic compounds useful as growth hormone secretagogues
CN101189006A (zh) * 2005-04-07 2008-05-28 康福玛医药公司 基于磷脂的药物制剂及其生产和使用方法
EP1931199A4 (en) 2005-08-31 2009-07-29 Univ Tennessee Res Foundation TREATMENT OF RENAL DISEASE, BURNS, INJURIES OR SPINAL CORD INJURY USING ANDROGEN RECEPTOR SELECTIVE MODULATORS
CA2631680A1 (en) * 2005-12-01 2007-06-07 Conforma Therapeutics Corporation Compositions containing ansamycin
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
CA2658394C (en) 2006-07-12 2016-08-16 University Of Tennessee Research Foundation Substituted acylanilides and methods of use thereof
US8299248B2 (en) 2006-08-02 2012-10-30 Cytokinetics, Incorporated Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
PT2583970E (pt) 2006-08-02 2016-02-08 Cytokinetics Inc Certas entidades químicas, composições e métodos compreendendo imidazopirimidinas
US9844528B2 (en) 2006-08-24 2017-12-19 University Of Tennessee Research Foundation SARMs and method of use thereof
US9730908B2 (en) 2006-08-24 2017-08-15 University Of Tennessee Research Foundation SARMs and method of use thereof
DK2054049T3 (en) 2006-08-24 2016-08-01 Univ Tennessee Res Found SUBSTITUTED ACYLANILIDES AND PROCEDURES FOR USING THEREOF
US10010521B2 (en) 2006-08-24 2018-07-03 University Of Tennessee Research Foundation SARMs and method of use thereof
ES2602789T3 (es) 2007-02-09 2017-02-22 Ocera Therapeutics, Inc. Productos intermedios conectores para la síntesis de moduladores macrocíclicos del receptor de la grelina
WO2008134828A2 (en) 2007-05-04 2008-11-13 Katholieke Universiteit Leuven Tissue degeneration protection
AU2008287421A1 (en) * 2007-08-10 2009-02-19 Glaxosmithkline Llc Nitrogen containing bicyclic chemical entities for treating viral infections
US7968603B2 (en) 2007-09-11 2011-06-28 University Of Tennessee Research Foundation Solid forms of selective androgen receptor modulators
US8003689B2 (en) * 2008-06-20 2011-08-23 Gtx, Inc. Metabolites of selective androgen receptor modulators and methods of use thereof
US20100204265A1 (en) * 2009-02-09 2010-08-12 Genelabs Technologies, Inc. Certain Nitrogen Containing Bicyclic Chemical Entities for Treating Viral Infections
BRPI0921118B1 (pt) 2009-04-09 2019-04-09 Intervet International B.V. Método para fabricar zearalenol
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
EP2560488B1 (en) 2010-04-23 2015-10-28 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
WO2013190520A2 (en) 2012-06-22 2013-12-27 The General Hospital Corporation Gh-releasing agents in the treatment of vascular stenosis and associated conditions
US9969683B2 (en) 2012-07-13 2018-05-15 Gtx, Inc. Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS)
US9744149B2 (en) 2012-07-13 2017-08-29 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US9622992B2 (en) 2012-07-13 2017-04-18 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US10258596B2 (en) 2012-07-13 2019-04-16 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
US10987334B2 (en) 2012-07-13 2021-04-27 University Of Tennessee Research Foundation Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs)
KR102238970B1 (ko) 2012-07-13 2021-04-09 지티엑스, 인코포레이티드 선택적 안드로겐 수용체 조절자(sarms)를 이용한 안드로겐 수용체(ar) 양성 유방암의 치료 방법
US10314807B2 (en) 2012-07-13 2019-06-11 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
NZ707752A (en) 2012-12-03 2020-01-31 Pfizer Novel selective androgen receptor modulators
US10092627B2 (en) 2013-04-08 2018-10-09 President And Fellows Of Harvard College Methods and compositions for rejuvenating skeletal muscle stem cells
WO2015181676A1 (en) 2014-05-30 2015-12-03 Pfizer Inc. Carbonitrile derivatives as selective androgen receptor modulators
EP3990447A1 (en) 2019-06-27 2022-05-04 Cytokinetics, Inc. Polymorphs of 1-(2-((((trans)-3-fluoro-1-(3-fluoropyridin-2-yl)cyclobutyl)methyl)amino)pyrimidin-5-yl)-1h-pyrrole-3-carboxamide
WO2023275715A1 (en) 2021-06-30 2023-01-05 Pfizer Inc. Metabolites of selective androgen receptor modulators

Also Published As

Publication number Publication date
BE675969A (US08124317-20120228-C00026.png) 1966-06-16
DK115777B (da) 1969-11-10
IL25085A (en) 1969-11-12
US3239345A (en) 1966-03-08
SE356428B (US08124317-20120228-C00026.png) 1973-05-28
GB1107738A (en) 1968-03-27
ES322894A1 (es) 1967-03-16
DE1543395B1 (de) 1971-04-22
NL6601185A (US08124317-20120228-C00026.png) 1966-08-16
DK119509B (da) 1971-01-18
BR6676850D0 (pt) 1973-09-06
SE347258B (US08124317-20120228-C00026.png) 1972-07-31
AT267772B (de) 1969-01-10

Similar Documents

Publication Publication Date Title
CH473116A (de) Verfahren zur Herstellung von Lactonen und deren Verwendung
CH479579A (de) Verfahren zur Herstellung von Lactonen und deren Verwendung
CH516519A (de) Verfahren zur Herstellung von Asparaginsäurederivaten und deren Verwendung
CH486500A (de) Verfahren zur Herstellung von fluorierten Polymerisaten und deren Verwendung
CH551441A (de) Verfahren zur herstellung von butyrophenonderivaten und deren verwendung.
CH461102A (de) Verfahren zur Herstellung von Polyestern und deren Verwendung
CH504414A (de) Verfahren zur Herstellung von neuen 2-Ureido-benzamiden und deren Verwendung zur Unkrautbekämpfung
CH532617A (de) Verfahren zur Herstellung von selbstvernetzenden Polymerisaten und deren Verwendung
AT273988B (de) Verfahren zur Herstellung von neuen Benzolsulfonylharnstoffen und deren Salzen
CH493329A (de) Verfahren zur Herstellung von Laminaten und deren Verwendung
CH484113A (de) Verfahren zur Herstellung von Isoindolonen und deren Verwendung
CH459223A (de) Verfahren zur Herstellung von e-Caprolactam und w-Dodecalactam
CH553772A (de) Verfahren zur herstellung von 3-aminocardenoliden und deren verwendung zur herstellung der entsprechenden 3acylaminocardenolide.
CH512544A (de) Verfahren zur Herstellung von Polydimercapto-s-triazinen und deren Verwendung als Klebstoffe
AT273987B (de) Verfahren zur Herstellung von neuen Benzolsulfonylharnstoffen und deren Salzen
CH491177A (de) Verfahren zur Herstellung von Farbsalzen und deren Verwendung
CH473096A (de) Verfahren zur Herstellung von Carbamaten und deren Verwendung
CH522578A (de) Verfahren zur Herstellung von Ketonen und deren Verwendung
CH550167A (de) Verfahren zur herstellung von diarylpiperidinen und deren verwendung.
CH466251A (de) Verfahren zur Herstellung von Jodhydrinen und deren Verwendung zur Herstellung von cyclischen Äthern
CH477478A (de) Verfahren zur Herstellung von Phosphoramidothioaten und deren Verwendung
CH479528A (de) Verfahren zur Herstellung von Allyl-B-phenyl- bzw. Allyl-B-alkylphenylpropionaten und deren Verwendung
CH521951A (de) Verfahren zur Herstellung von Carbamaten und deren Verwendung
CH463118A (de) Verfahren zur Herstellung von Polyestern und deren Verwendung
AT273997B (de) Verfahren zur Herstellung von neuen Benzolsulfonylharnstoffen und deren Salzen

Legal Events

Date Code Title Description
PL Patent ceased